MENU

Bull vs Bear: GlaxoSmithKline Plc

If you are looking for other buying opportunities, this new wealth report identifies five FTSE names that should provide you with a comfortable retirement. Just click here for details — it’s absolutely free.

In this Motley Fool video, Nate Weisshaar and Jill Ralph discuss the finer points of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) as an investment opportunity.